Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach

    Information on the distribution of chemotherapeutic drugs to breast milk is scarce, and reports are limited to small sample sizes. Anecdotal pharmacokinetic data have typically been acquired from lactating but...

    David Damoiseaux, Daniel Centanni, Jos H. Beijnen in Clinical Pharmacokinetics (2023)

  2. No Access

    Article

    Noninvasive prenatal screening and maternal malignancy: role of imaging

    Noninvasive prenatal screening (NIPS) tests for fetal chromosomal anomalies through maternal blood sampling. It is becoming widely available and standard of care for pregnant women in many countries. It is per...

    Priyanka Jha, Liesbeth Lenaerts, Joris Vermeesch, Mary Norton in Abdominal Radiology (2023)

  3. No Access

    Article

    Effects of chemotherapy on ovaries of pregnant mice

    It is unknown if future fertility is compromised by the administration of chemotherapy during pregnancy. The aim of this study was to identify if chemotherapy affects the maternal ovaries during pregnancy and ...

    Teska Schuurman, Ji-Ying Song, Vera Wolters in Archives of Gynecology and Obstetrics (2023)

  4. Article

    Open Access

    Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

    A phase II study (PRIMMO) of patients with pretreated persistent/recurrent/metastatic cervical or endometrial cancer is presented. Patients received an immunomodulatory five-drug cocktail (IDC) consisting of l...

    Emiel A. De Jaeghere, Sandra Tuyaerts in Cancer Immunology, Immunotherapy (2023)

  5. Article

    Open Access

    Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

    Resistance to platinum-based chemotherapy represents a major clinical challenge for many tumors, including epithelial ovarian cancer. Patients often experience several response-relapse events, until tumors bec...

    Tom Van Nyen, Mélanie Planque, Lilian van Wagensveld in Nature Communications (2022)

  6. Article

    Open Access

    Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT)

    With the aim of obtaining more uniformity and quality in the treatment of corpus uteri cancer in Belgium, the EFFECT project has prospectively collected detailed information on the real-world clinical care off...

    Joren Vanbraband, Nancy Van Damme, Gauthier Bouche, Geert Silversmit in BMC Cancer (2022)

  7. Article

    Open Access

    TRP channel expression correlates with the epithelial–mesenchymal transition and high-risk endometrial carcinoma

    Transient receptor potential (TRP) channels excel in cellular sensing as they allow rapid ion influx across the plasma membrane in response to a variety of extracellular cues. Recently, a distinct TRP mRNA exp...

    Charlotte Van den Eynde, Katrien De Clercq in Cellular and Molecular Life Sciences (2021)

  8. Article

    Open Access

    The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

    Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, lacking effective therapy. Many TNBCs show remarkable response to carboplatin-based chemotherapy, but often develop resistance...

    Stijn Moens, Peihua Zhao, Maria Francesca Baietti, Oliviero Marinelli in Scientific Reports (2021)

  9. Article

    Open Access

    Pregnancy and Cancer: the INCIP Project

    Cancer diagnosis in young pregnant women challenges oncological decision-making. The International Network on Cancer, Infertility and Pregnancy (INCIP) aims to build on clinical recommendations based on worldw...

    Charlotte Maggen, Vera E. R. A. Wolters, Elyce Cardonick in Current Oncology Reports (2020)

  10. Article

    Open Access

    Influence of the corticospinal tract wiring pattern on sensorimotor functional connectivity and clinical correlates of upper limb function in unilateral cerebral palsy

    In children with unilateral cerebral palsy (uCP), the corticospinal tract (CST)-wiring patterns may differ (contralateral, ipsilateral or bilateral), partially determining motor deficits. However, the impact o...

    Cristina Simon-Martinez, Ellen Jaspers, Kaat Alaerts, Els Ortibus in Scientific Reports (2019)

  11. Article

    Open Access

    PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

    Immunotherapeutic approaches have revolutionized oncological practice but are less evaluated in gynecological malignancies. PD-1/PD-L1 blockade in gynecological cancers showed objective responses in 13–17% of ...

    Sandra Tuyaerts, An M. T. Van Nuffel, Eline Naert, Peter A. Van Dam in BMC Cancer (2019)

  12. No Access

    Protocol

    Development of Patient-Derived Tumor Xenograft Models

    In spite of the latest advancements in understanding cancer development and progression, drugs successful in preclinical testing often fail upon reaching phase III clinical trials. A reason for this is the use...

    Daniela Annibali, Eleonora Leucci, Els Hermans, Frédéric Amant in Metabolic Signaling (2019)

  13. No Access

    Article

    Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study

    To evaluate the feasibility of whole-body diffusion-weighted MRI (WB-DWI/MRI) for detecting primary tumour, nodal and distant metastases in pregnant women with cancer.

    Sileny N. Han, Frédéric Amant, Katrijn Michielsen, Frederik De Keyzer in European Radiology (2018)

  14. Article

    Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts

    Nature Reviews Cancer 17, 254–268 (2017) In the online html version of this article, Joan Seoane's affiliations were not correct. He is also a member of the EurOPDX Consortium and is at the Vall d'Hebron Insti...

    Annette T. Byrne, Denis G. Alférez, Frédéric Amant in Nature Reviews Cancer (2017)

  15. Article

    Open Access

    Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients

    Several studies have identified L1 cell adhesion molecule (L1CAM) as a strong prognostic marker in endometrial cancer. To further underline the clinical usefulness of this biomarker, we investigated L1CAM as a...

    Ingvild L Tangen, Reidun K Kopperud, Nicole CM Visser in British Journal of Cancer (2017)

  16. No Access

    Article

    Interrogating open issues in cancer precision medicine with patient-derived xenografts

    This Opinion article discusses progress and challenges in using patient-derived xenograft (PDX) models in cancer precision medicine. It is primarily co-authored by members of the EurOPDX Consortium and as such...

    Annette T. Byrne, Denis G. Alférez, Frédéric Amant in Nature Reviews Cancer (2017)

  17. No Access

    Article

    A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors

    This Phase I dose-escalation study (NCT00058526) assessed the safety and immunogenicity of an anti-cancer immunotherapeutic (recombinant HER2 protein (dHER2) combined with the immunostimulant AS15) in patients...

    Steven A. Limentani, Mario Campone, Thierry Dorval in Breast Cancer Research and Treatment (2016)

  18. No Access

    Protocol

    mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70)

    The immune system is a crucial player in the development of cancer. Once it is in imbalance and immunosuppressive mechanisms supporting tumor growth take over control, dendritic cell immunotherapy might offer ...

    An Coosemans M.D. Ph.D., Sandra Tuyaerts, Kim Morias, Jurgen Corthals in Synthetic mRNA (2016)

  19. No Access

    Article

    Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas

    Clinical outcome of 23 patients with mixed endometrioid and serous endometrial carcinomas (mixed EEC-SC) was compared to that of pure endometrioid (EEC) and pure serous (SC) carcinomas. Hotspot mutation freque...

    L. Coenegrachts, D. A. Garcia-Dios, J. Depreeuw, M. Santacana, S. Gatius in Virchows Archiv (2015)

  20. Article

    Open Access

    Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

    This study aimed to determine whether single nucleotide polymorphisms (SNPs) in genes involved in DNA repair or metabolism of taxanes or platinum could predict toxicity or response to first-line chemotherapy i...

    Sandrina Lambrechts, Diether Lambrechts in BMC Pharmacology and Toxicology (2015)

previous disabled Page of 2